The price of Astrana Health Inc. (ASTH) on October 9, 2026 is 37.67 USD, +5.02% on the day. Over 52 weeks the stock traded between 18.08 USD and 51.60 USD; the price now sits 53% of the way up that range. Over the past year the price changed by +18.27%. The P/E ratio is 58.0, which is above the sector median (26.0). Market capitalization is 1.75 billion USD, rank 6 among 21 stocks of the same industry with a known capitalization.
Prices delayed by 15 minutes
Next earnings report: none scheduled in the next five weeks · Earnings calendar
Astrana Health Inc. trades on Nasdaq under the ticker ASTH. The company belongs to the Industrials sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks ASTH has traded between 18.08 $ and 51.60 $. As of 09 October 2026 the price stood 53.07 % of the way from the 52-week low to the high.
Over one year ASTH shares rose 18.27 %; over six months they rose 27.06 %. Volatility over 90 days is 49.21 %. Dividends are not included: this is price change only, as of 09 October 2026.
ASTH trades at a price-to-earnings ratio of 58.0, above the sector median of 26.0. Price to sales is 0.5, below the sector median of 1.3. Price to book is 2.2, below the sector median of 2.6. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 08 October 2026 | 36.81 | 36.96 | 35.38 | 35.87 | 351,100 |
| 07 October 2026 | 36.65 | 37.66 | 36.65 | 37.14 | 664,500 |
| 06 October 2026 | 37.12 | 37.70 | 36.78 | 37.00 | 227,100 |
| 05 October 2026 | 35.73 | 37.06 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Astrana Health Inc. (ASTH) is a public company in the industrials sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2025-12-31, revenue was 3.2bn $, net income was 22.5m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Address:1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA, CA, 91801, US
Astrana Health Inc. reported revenue of 3.5B $ and net income of 30M $ over the last four quarters. Net margin is 0.86 %. Revenue changed by +56.69 % year over year. Earnings per share are 0.61 $. Market capitalisation is 1.8B $.
ASTH has a return on equity of 3.78 %, below the sector median of 5.92 %. Return on assets is 1.28 %, below the sector median of 2.51 %. Operating margin is 2.45 %, below the sector median of 4.32 %.
| 38M |
| EXPOExponent, Inc. | 70.10 | +0.45 % | 38M |
| GIBCGI Inc. | 70.09 | +0.59 % | 31M |
| ICFIICF International, Inc. | 88.14 | +1.51 % | 16M |
| BWMNBowman Consulting Group Ltd. | 42.79 | +0.01 % | 14M |
| 35.73 |
| 36.81 |
| 389,900 |
| 02 October 2026 | 35.53 | 36.39 | 35.11 | 35.88 | 310,400 |
| 01 October 2026 | 35.61 | 35.68 | 34.71 | 34.91 | 266,800 |
| 30 September 2026 | 35.49 | 35.97 | 34.81 | 35.57 | 398,900 |
| 29 September 2026 | 35.09 | 35.66 | 34.46 | 35.45 | 264,300 |
| 28 September 2026 | 36.29 | 36.83 | 34.74 | 35.13 | 363,600 |
| 25 September 2026 | 34.46 | 36.41 | 34.11 | 36.37 | 336,600 |
| 24 September 2026 | 34.32 | 34.54 | 33.54 | 34.44 | 391,500 |
| 23 September 2026 | 33.08 | 34.46 | 32.22 | 34.34 | 405,100 |
| 22 September 2026 | 34.11 | 35.52 | 33.40 | 35.11 | 409,500 |
| 21 September 2026 | 34.40 | 34.44 | 32.22 | 33.55 | 603,500 |
| 18 September 2026 | 33.87 | 35.22 | 33.14 | 34.36 | 1M |
| 17 September 2026 | 37.96 | 38.16 | 34.17 | 34.30 | 1M |
| 16 September 2026 | 38.35 | 39.52 | 37.60 | 37.70 | 263,400 |
| 15 September 2026 | 39.70 | 39.70 | 38.00 | 38.35 | 314,300 |
| 14 September 2026 | 38.21 | 39.95 | 38.21 | 39.60 | 321,300 |
| 11 September 2026 | 38.45 | 38.88 | 37.59 | 37.98 | 191,700 |